4/A: Edgewise Therapeutics Executive Receives Stock Grant
Insider Transaction (Form 4/A)
Behrad Derakhshan, Chief Business Officer of Edgewise Therapeutics, Inc., received 100,000 shares of common stock on August 12, 2026.
Summary
- Grant/award: acquired 100,000 Stock Option (Right to Buy) on August 12, 2026; holds 100,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Behrad Derakhshan — Officer (Chief Business Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-12 | Grant/award | Stock Option (Right to Buy) | 100,000 | — | — | 100,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-12 | Grant/award (100,000 shares) |
Keywords
insider transaction, Form 4/A, EWTX, Edgewise Therapeutics, Inc., neutral, Behrad Derakhshan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.